Back
  1. Home
  3. Detailled Reference
Request a copy
Paper published in a journal (Scientific congresses and symposiums)
PO004LBA/#1515  Efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer following prior systemic therapy
Grisham, Rachel; Aghajanian, Carol; Nieuwenhuysen, Els Van et al.
2023 • In International Journal of Gynecological Cancer
Peer reviewed
Permalink
https://hdl.handle.net/2268/311324
DOI
10.1136/ijgc-2023-igcs.4
 

Files (1)Send toDetailsStatisticsBibliographySimilar publications

Files

Full Text
A3.full.pdf
Publisher postprint (1.32 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to


Details


Disciplines :
Oncology
Author, co-author :
Grisham, Rachel
Aghajanian, Carol
Nieuwenhuysen, Els Van
Rodrigues, Manuel
Ring, Kari
Santin, Alessandro
Colombo, Nicoletta
Prendergast, Emily
Thaker, Premal
Moore, Kathleen
Salinas, Erin
Ray-Coquard, Isabelle
Chon, Hye Sook
Rose, Peter
Oaknin, Ana
Clamp, Andrew
Gandhi, Mitul
Monk, Bradley
Holloway, Robert
Gorp, Toon Van
Fabbro, Michel
Gennigens, Christine  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service d'oncologie médicale
Wojtynek, Nicholas
Lustgarten, Stephanie
Banerjee, Susana
More authors (15 more) Less
Language :
English
Title :
PO004LBA/#1515  Efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer following prior systemic therapy
Publication date :
November 2023
Event name :
IGCS 2023
Event place :
Seoul, South Korea
Event date :
5-7 November 2023
Audience :
International
Journal title :
International Journal of Gynecological Cancer
ISSN :
1048-891X
eISSN :
1525-1438
Publisher :
BMJ Publishing Group Ltd
Peer reviewed :
Peer reviewed
Additional URL :
https://syndication.highwire.org/content/doi/10.1136/ijgc-2023-IGCS.4
Available on ORBi :
since 16 January 2024

Statistics

Number of views
68 (2 by ULiège)
Number of downloads
0 (0 by ULiège)
More statistics

Bibliography

Similar publications


Contact ORBi